0001171843-22-004515.txt : 20220623
0001171843-22-004515.hdr.sgml : 20220623
20220623163407
ACCESSION NUMBER: 0001171843-22-004515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220622
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ford Brian D.
CENTRAL INDEX KEY: 0001825758
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 221035916
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
BUSINESS PHONE: 450-686-4555
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
4
1
ownership.xml
X0306
4
2022-06-22
0
0001444192
Acasti Pharma Inc.
ACST
0001825758
Ford Brian D.
C/O ACASTI PHARMA INC.
3009 BOUL. DE LA CONCORDE, SUITE 102
LAVAL
A6
H7E 2B5
ONTARIO, CANADA
0
1
0
0
CHIEF FINANCIAL OFFICER
Stock Options (Right to Buy)
0.89
2022-06-22
4
A
0
165000
0
A
2032-06-22
Class A Common Shares
165000
165000
D
Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant.
Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.
/s/ Jason Comerford, attorney-in fact for Mr. Ford
2022-06-23